The prevalence of dental developmental anomalies among childhood cancer survivors according to types of anticancer treatment.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
16 03 2022
16 03 2022
Historique:
received:
11
07
2021
accepted:
02
03
2022
entrez:
17
3
2022
pubmed:
18
3
2022
medline:
6
5
2022
Statut:
epublish
Résumé
Survival following childhood cancer has increased considerably. In an observational cross-sectional study, we assessed the prevalence of dental developmental anomalies (DDA) among childhood cancer survivors according to types of anticancer treatment. Permanent teeth were examined clinically and radiographically in 121 adolescents with a history of childhood malignancies, to identify DDA, namely hypomineralization or hypoplasia, microdontia, root changes and hypodontia. DDA were observed in 56/121 individuals (46%), in 309/3388 teeth (9%). Hypomineralization or hypoplasia of enamel appeared in 21 (17%) patients. Altered root development appeared in 26 patients and hypodontia affected 13 (10%). Dental anomalies were observed in 36 (43%) individuals who received chemotherapy and not radiation, in 20 (52%) who received radiotherapy, and in 15 (60%) of those who received head and neck radiotherapy. Among patients who received only chemotherapy, young age (6 years or younger) was associated with a higher number of malformed teeth. In conclusion, antineoplastic treatment that combines chemotherapy and radiotherapy appears to increase the risk of DDA. Radiation to the head and neck area was shown to particularly increase the risk of DDA. No specific chemotherapy agent was found to be associated more than the others with DDA.
Identifiants
pubmed: 35296697
doi: 10.1038/s41598-022-08266-1
pii: 10.1038/s41598-022-08266-1
pmc: PMC8927608
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4485Informations de copyright
© 2022. The Author(s).
Références
Cancer. 2009 Dec 15;115(24):5817-27
pubmed: 19834960
Cancer Res Treat. 2016 Apr;48(2):658-67
pubmed: 26511809
Eur J Oral Sci. 1997 Oct;105(5 Pt 1):444-7
pubmed: 9395106
J Clin Oncol. 2004 Dec 15;22(24):4979-90
pubmed: 15576413
Cancer. 1990 Dec 15;66(12):2645-52
pubmed: 2249205
Pediatr Dent. 2000 Jan-Feb;22(1):57-62
pubmed: 10730289
Caries Res. 2006;40(2):130-5
pubmed: 16508270
Quintessence Int. 1995 Jun;26(6):405-11
pubmed: 8602421
Pediatr Blood Cancer. 2009 Sep;53(3):361-5
pubmed: 19484760
Pediatr Dent. 2016 Oct;38(6):334-342
pubmed: 27931474
Pediatr Dent. 2019 Sep 15;41(5):364-370
pubmed: 31648667
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Dec;104(6):781-9
pubmed: 17618135
Cancer. 2011 May 15;117(10):2219-27
pubmed: 21523736
Pediatr Blood Cancer. 2014 Mar;61(3):407-16
pubmed: 24424790
Cancer. 2005 Jan 1;103(1):181-90
pubmed: 15540242
Cancer Res Treat. 2018 Jul;50(3):926-935
pubmed: 29020731
Cancer. 2005 Apr 1;103(7):1484-93
pubmed: 15739206
Community Dent Health. 2005 Sep;22(3):175-9
pubmed: 16161882
Pediatr Blood Cancer. 2004 Jul;43(1):88-90
pubmed: 15170898
Leuk Res. 2003 Jan;27(1):45-50
pubmed: 12479851
Leukemia. 1997 Jun;11(6):792-6
pubmed: 9177429
Eur J Dent. 2007 Jul;1(3):167-73
pubmed: 19212561
Clinics (Sao Paulo). 2014 Jun;69(6):433-7
pubmed: 24964309
Caries Res. 1988;22(5):318-20
pubmed: 3263210
Oral Oncol. 2018 Aug;83:64-72
pubmed: 30098781
Int J Paediatr Dent. 2012 Jul;22(4):239-43
pubmed: 22092748
Bone Marrow Transplant. 2002 Jan;29(2):121-7
pubmed: 11850706
Lancet Oncol. 2006 Apr;7(4):326-35
pubmed: 16574548
Pediatr Blood Cancer. 2008 Jun;50(6):1221-6
pubmed: 18273868
Support Care Cancer. 2019 May;27(5):1891-1899
pubmed: 30203360